A Phase IIa Cancer Prevention Trial of the PPAR Gamma Ag

Project: Research project

Project Details

Description

A Phase IIa Cancer Prevention Trial of the PPAR Gamma Agonist Pioglitazone in Oral Leukoplakia
StatusFinished
Effective start/end date9/30/019/29/07

Funding

  • NIH NATIONAL CANCER INSTITUTE (NCI)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.